China's pharmaceutical market is the second largest in Asia, worth $22.5 billion, and will likely increase upon China's entrance into the WTO. In March 1998, the Chinese government created the State Drug Administration (SDA) to oversee drug importation, improving the enforcement and... Read More
The Asian pharmaceutical market is constantly expanding with Korea, Japan and Taiwan leading the way. The Philippines is no exception and it is currently the fourth largest pharmaceutical market in Asia. In 1999 alone, the Filipino pharmaceutical market saw a 5% increase.... Read More
While many countries are experiencing significant increases in medical costs, Taiwan has kept its healthcare expenditures to a minimum and is still able to provide services to over 96% of its citizens. Additionally, Taiwan’s Department of Health (DOH) is working to promote... Read More
This article explains some of the basic features of Vietnam’s healthcare system and how its imported pharmaceuticals and medical equipment market is growing. While Vietnam’s healthcare system is centralized, the Ministry of Health (MoH) is eager to improve healthcare facilities and healthcare... Read More
This article is a review of Vietnam’s small, but expanding pharmaceutical market. Growing demand and weak domestic production are encouraging foreign companies to sell and distribute their drugs and pharmaceuticals in Vietnam. Foreign companies can be successful in Vietnam if they study... Read More
China's pharmaceutical market is booming, and with the formation of the State Drug Administration (SDA) in 1998, enforcement of pharmaceutical regulations has greatly improved. An increase in drug supervision, through stricter punishments for drug research, declaration and registration violations, was implemented by... Read More
Recent deregulation reforms within the Japanese pharmaceutical market have been applauded by international pharmaceutical companies and associations alike. Major reform efforts include: withdrawal of the reference pricing system, speeding up the approval process for new drugs, more acceptance of foreign clinical data,... Read More
As South Korea's economy rebounds from the Asian financial crisis, its pharmaceutical and medical device markets are also rebounding due to increased demand and consumption. Part of the Korean government's economic reforms include the deregulation of its markets and promoting of foreign... Read More
Thanks to significant government reform efforts since 1998, the Malaysian economy has been able to rebound from the Asian currency crisis of 1997. The costs of healthcare in Malaysia are on the rise and the government is looking to cut healthcare expenditure,... Read More
This article contains a series of news briefs and updates with regard to Japan's medical device and pharmaceutical markets. Topics include: hospital roles in billing, reimbursing, and controlling medical equipment; pharmaceutical deregulation; liberalized procurement policy for medical products; and drug pricing policy. Read More